New materials improve delivery of therapeutic messenger RNA
Polymeric nanoparticles can efficiently administer mRNA to cells of the lungs, liver, and other organs.
Polymeric nanoparticles can efficiently administer mRNA to cells of the lungs, liver, and other organs.
Drugs carried in cellular “backpacks” help T cells to destroy tumors.
Researchers identify the amino acid aspartate as a metabolic limitation in certain cancers.
Shortfall of digestive enzymes can lead to tissue breakdown in early stages of pancreatic cancer.
Researchers generate an intestinal cell mimic that can be harnessed in studies of diseases such as inflammatory bowel disease.
Institute Professor chosen to help forge connections and identify opportunities for sustained international cooperation.
Scientists leverage one step, unbiased method to characterize the binding preferences of more than 70 human RNA-binding proteins.
New technology could enable remote control of drug delivery, sensing, and other medical applications.
Nanoparticles carrying two drugs can cross the blood-brain barrier and shrink glioblastoma tumors.
MIT faculty members are among 19 top scientists selected from across the nation.
Nanoparticles could offer a new way to help eradicate the disease worldwide.
Startup develops implantable, encased cells that live in the body and secrete insulin and other therapeutics.
Study in worms reveals gene loss can lead to accumulation of waste products in cells.
A drug treatment that mimics fasting can also provide the same benefit, study finds.
New fellowship program honoring trailblazing Nobel laureate awards four MIT postdocs focused on drug discovery and development.